Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have finished the full treatment period of the related previous study (called the "parent study")
- People who agree to follow the birth control requirements set out by the trial
- People who attended their follow-up visit in the parent study and showed improvement in their joint swelling and tenderness counts compared to when they started
Who may not be able to join:
- People who withdrew their consent or stopped participating in the parent study early for any reason
- People whose study medication was permanently stopped at any point during the parent study
- People who used a treatment or therapy that was not allowed during the parent study
- People who have developed a new or poorly controlled health condition that, in the investigator's judgement, would make participation in this trial unsafe or unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trials, Hoffmann-La Roche
Phone: 888-662-6728
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants With Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.